EdgarLookup

CHIMERA INVESTMENT CORP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that CHIMERA INVESTMENT CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
0.2%
Return on Assets
Net income ÷ assets
5.14x
Debt-to-Equity
Total liabilities ÷ equity

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $28.33M Feb 18, 2026
FY2025 Sep 30, 2025 ($580.0K) Feb 18, 2026
FY2025 Jun 30, 2025 $35.45M Feb 18, 2026
FY2025 Mar 31, 2025 $167.30M Feb 18, 2026
FY2025 Dec 31, 2024 ($146.51M) Feb 18, 2026
FY2025 Sep 30, 2024 $136.46M Feb 18, 2026
FY2025 Jun 30, 2024 $56.66M Feb 18, 2026
FY2025 Mar 31, 2024 $129.45M Feb 18, 2026
FY2024 Dec 31, 2023 $30.54M Feb 19, 2025
FY2024 Sep 30, 2023 $2.17M Feb 19, 2025

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($248.88M) Feb 18, 2026
FY2025 Dec 31, 2024 $205.67M Feb 18, 2026
FY2025 Dec 31, 2023 $213.27M Feb 18, 2026
FY2024 Dec 31, 2022 $325.72M Feb 19, 2025
FY2023 Dec 31, 2021 $519.18M Feb 29, 2024
FY2022 Dec 31, 2020 $257.90M Feb 17, 2023
FY2021 Dec 31, 2019 $65.04M Feb 17, 2022
FY2020 Dec 31, 2018 $297.58M Feb 18, 2021
FY2019 Dec 31, 2017 $487.29M Feb 24, 2020
FY2018 Dec 31, 2016 $552.91M Feb 21, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $15.81B Feb 18, 2026
FY2025 Dec 31, 2024 $13.12B Feb 18, 2026
FY2024 Dec 31, 2023 $12.93B Feb 19, 2025
FY2023 Dec 31, 2022 $13.40B Feb 29, 2024
FY2022 Dec 31, 2021 $15.41B Feb 17, 2023
FY2021 Dec 31, 2020 $17.52B Feb 17, 2022
FY2020 Dec 31, 2019 $27.12B Feb 18, 2021
FY2019 Dec 31, 2018 $27.71B Feb 24, 2020
FY2018 Dec 31, 2017 $21.22B Feb 21, 2019
FY2017 Dec 31, 2016 $16.68B Feb 20, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $13.24B Feb 18, 2026
FY2025 Dec 31, 2024 $10.59B Feb 18, 2026
FY2024 Dec 31, 2023 $10.37B Feb 19, 2025
FY2023 Dec 31, 2022 $10.74B Feb 29, 2024
FY2022 Dec 31, 2021 $11.67B Feb 17, 2023
FY2021 Dec 31, 2020 $13.74B Feb 17, 2022
FY2020 Dec 31, 2019 $23.17B Feb 18, 2021
FY2019 Dec 31, 2018 $24.00B Feb 24, 2020
FY2018 Dec 31, 2017 $17.59B Feb 21, 2019
FY2017 Dec 31, 2016 $13.56B Feb 20, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.57B Feb 18, 2026
FY2025 Dec 31, 2024 $2.53B Feb 18, 2026
FY2025 Dec 31, 2023 $2.56B Feb 18, 2026
FY2025 Dec 31, 2022 $2.67B Feb 18, 2026
FY2024 Dec 31, 2021 $3.74B Feb 19, 2025
FY2023 Dec 31, 2020 $3.78B Feb 29, 2024
FY2022 Dec 31, 2019 $3.95B Feb 17, 2023
FY2021 Dec 31, 2018 $3.70B Feb 17, 2022
FY2020 Dec 31, 2017 $3.63B Feb 18, 2021
FY2019 Dec 31, 2016 $3.12B Feb 24, 2020

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.57B Feb 18, 2026
FY2025 Dec 31, 2024 $4.34B Feb 18, 2026
FY2024 Dec 31, 2023 $4.17B Feb 19, 2025
FY2023 Dec 31, 2022 $4.04B Feb 29, 2024
FY2022 Dec 31, 2021 $4.55B Feb 17, 2023
FY2021 Dec 31, 2020 $3.88B Feb 17, 2022
FY2020 Dec 31, 2019 $3.79B Feb 18, 2021
FY2019 Dec 31, 2018 $3.38B Feb 24, 2020
FY2018 Dec 31, 2017 $2.97B Feb 21, 2019
FY2017 Dec 31, 2016 $2.44B Feb 20, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $278.58M Feb 18, 2026
FY2025 Dec 31, 2024 $84.00M Feb 18, 2026
FY2024 Dec 31, 2023 $221.68M Feb 19, 2025
FY2023 Dec 31, 2022 $264.60M Feb 29, 2024
FY2022 Dec 31, 2021 $385.74M Feb 17, 2023
FY2021 Dec 31, 2020 $269.09M Feb 17, 2022
FY2020 Dec 31, 2019 $109.88M Feb 18, 2021
FY2019 Dec 31, 2018 $47.49M Feb 24, 2020
FY2018 Dec 31, 2017 $63.57M Feb 21, 2019
FY2018 Dec 31, 2016 $177.71M Feb 21, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $251.53M Feb 18, 2026
FY2025 Dec 31, 2024 $134.65M Feb 18, 2026
FY2024 Dec 31, 2023 $0 Feb 19, 2025
FY2021 Dec 31, 2021 $0 Feb 17, 2022
FY2021 Dec 31, 2020 $51.62M Feb 17, 2022
FY2020 Dec 31, 2019 $0 Feb 18, 2021

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Feb 18, 2026
FY2025 Sep 30, 2025 0 Feb 18, 2026
FY2025 Jun 30, 2025 0 Feb 18, 2026
FY2025 Mar 31, 2025 1 Feb 18, 2026
FY2025 Dec 31, 2024 (2) Feb 18, 2026
FY2025 Sep 30, 2024 1 Feb 18, 2026
FY2025 Jun 30, 2024 0 Feb 18, 2026
FY2025 Mar 31, 2024 1 Feb 18, 2026
FY2024 Dec 31, 2023 0 Feb 19, 2025
FY2024 Sep 30, 2023 0 Feb 19, 2025

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 18, 2026
FY2025 Dec 31, 2024 1 Feb 18, 2026
FY2025 Dec 31, 2023 0 Feb 18, 2026
FY2024 Dec 31, 2022 (7) Feb 19, 2025
FY2023 Dec 31, 2021 2 Feb 29, 2024
FY2022 Dec 31, 2020 0 Feb 17, 2023
FY2021 Dec 31, 2019 1 Feb 17, 2022
FY2020 Dec 31, 2018 1 Feb 18, 2021
FY2019 Dec 31, 2017 2 Feb 24, 2020
FY2018 Dec 31, 2016 2 Feb 21, 2019

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 83.40M Feb 18, 2026
FY2025 Dec 31, 2024 80.92M Feb 18, 2026
FY2024 May 22, 2024 80.00M Feb 19, 2025
FY2024 May 21, 2024 241.00M Feb 19, 2025
FY2024 Dec 31, 2023 80.45M Feb 19, 2025
FY2023 Dec 31, 2022 231.82M Feb 29, 2024
FY2022 Dec 31, 2021 236.95M Feb 17, 2023
FY2021 Dec 31, 2020 230.56M Feb 17, 2022
FY2020 Dec 31, 2019 187.23M Feb 18, 2021
FY2019 Dec 31, 2018 187.05M Feb 24, 2020

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $122.70M Feb 18, 2026
FY2025 Dec 31, 2024 $119.08M Feb 18, 2026
FY2025 Dec 31, 2023 $195.22M Feb 18, 2026
FY2024 Dec 31, 2022 $287.75M Feb 19, 2025
FY2023 Dec 31, 2021 $298.64M Feb 29, 2024
FY2022 Dec 31, 2020 $322.63M Feb 17, 2023
FY2021 Dec 31, 2019 $374.26M Feb 17, 2022
FY2020 Dec 31, 2018 $374.40M Feb 18, 2021
FY2019 Dec 31, 2017 $375.77M Feb 24, 2020
FY2018 Dec 31, 2016 $454.28M Feb 21, 2019